Human Papillomavirus Infection
119
8
28
61
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
22 trials with published results (18%)
Research Maturity
61 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
4 terminated out of 119 trials
93.8%
+7.3% vs benchmark
13%
16 trials in Phase 3/4
36%
22 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 61 completed trials
Clinical Trials (119)
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPV
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)
Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study
Promoting HPV Vaccination Among Young Adults in Texas
Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Digital Telecytology for Triage of HPV-Positive Women in Cameroon
Self-sampling for Non-attenders to Cervical Cancer Screening
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Point of Care - Triage and Treatment for Cervical Pre-cancer